Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 17, 2018

SELL
$6.75 - $8.28 $215,790 - $264,703
-31,969 Closed
0 $0
Q1 2018

Apr 26, 2018

SELL
$6.93 - $8.27 $22,425 - $26,761
-3,236 Reduced 9.19%
31,969 $224,000
Q4 2017

Feb 05, 2018

BUY
$6.74 - $9.23 $57,249 - $78,399
8,494 Added 31.8%
35,205 $309,000
Q3 2017

Oct 30, 2017

BUY
$5.44 - $7.7 $145,307 - $205,674
26,711
26,711 $174,000

Others Institutions Holding ICCC

About IMMUCELL CORP


  • Ticker ICCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,746,860
  • Market Cap $28.7M
  • Description
  • ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...
More about ICCC
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.